Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2011

Conditions
Healthy
Interventions
DRUG

Matching placebo (low dose)

single dose of matching placebo

DRUG

BI 207127 NA (medium dose)

Single does of BI 207127 NA

DRUG

BI 207127 NA (low dose)

single dose of BI 207127 NA

DRUG

Matching placebo (medium dose)

Single dose of matching placebo

DRUG

BI 207127 NA (high dose)

Single dose of BI 207127 NA

DRUG

Matching placebo (high dose)

Single dose of matching placebo

Trial Locations (1)

Unknown

1241.8.8201 Boehringer Ingelheim Investigational Site, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY